• $22.8B
    Market Cap
  • 87.96%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
3.2B
+10.61%
2.9B
+23.63%
2.3B
+20.20%
1.9B
+14.88%
Cost of Revenue
384.4M
+24.12%
309.7M
+20.27%
257.5M
+69.85%
151.6M
+23.76%
Gross Profit
1.1B
-57.87%
2.6B
+24.04%
2.1B
+15.99%
1.8B
+14.18%
Sales and Marketing Expense
755.8M
+6.50%
709.7M
+48.75%
477.1M
N/A
N/A
N/A
Research and Development Expense
-550.0M
+14.35%
-481.0M
+17.89%
-408.0M
+26.35%
-322.9M
-40.21%
Depreciation and Amortization Expense
85.6M
+18.07%
72.5M
+36.28%
53.2M
+3.70%
51.3M
+2.81%
Total Operating Expenses
1.7B
+12.65%
1.5B
+31.31%
1.1B
+19.44%
956.6M
-15.32%
Operating Profit
1.5B
+8.39%
1.4B
+16.21%
1.2B
+20.95%
979.7M
+76.24%
Interest Income
192.0M
-3.57%
199.1M
+22.37%
162.7M
+259.96%
45.2M
+170.66%
Interest Expense
N/A
N/A
N/A
N/A
-59.3M
+83.02%
-32.4M
+74.19%
Interest Income and Expense and Net
192.0M
-3.57%
199.1M
+92.55%
103.4M
+707.81%
12.8M
+773.68%
Total Nonoperating Income and Expense
221.4M
+36.67%
162.0M
+81.21%
89.4M
+407.22%
-29.1M
-176.58%
Income before Taxes
1.7B
+11.36%
1.5B
+20.77%
1.3B
+34.05%
950.6M
+60.06%
Income Taxes
379.2M
+10.26%
343.9M
+18.79%
289.5M
+29.65%
223.3M
+89.08%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
1.3B
+11.68%
1.2B
+21.35%
984.8M
+35.40%
727.3M
+52.86%
Net Income from Continuing Operations Applicable to Common
1.7B
+11.36%
1.5B
+20.77%
1.3B
+75.21%
727.3M
+52.86%
Basic EPS and Net Income
30.13
+13.96%
26.44
+25.67%
21.04
+31.66%
15.98
+50.75%
Diluted EPS and Net Income
27.86
+13.07%
24.64
+24.38%
19.81
+32.07%
15.00
+49.11%
Basic Weighted Average Shares
44.3M
-1.99%
45.2M
-3.42%
46.8M
+2.86%
45.5M
+1.34%
Diluted Weighted Average Shares
47.9M
-1.24%
48.5M
-2.41%
49.7M
+2.47%
48.5M
+2.54%
Balance Sheet
Cash and Cash Equivalents
1.6B
-8.25%
1.7B
+40.53%
1.2B
+25.65%
961.2M
+7.42%
Short-Term Investments
1.4B
-13.16%
1.6B
-12.12%
1.8B
-4.85%
1.9B
+81.24%
Cash and Cash Equivalents and Short-Term Investments
2.9B
-10.61%
3.3B
+9.11%
3.0B
+5.47%
2.8B
+47.03%
Total Current Assets
3.7B
-4.42%
3.9B
+9.09%
3.6B
+5.05%
3.4B
+45.48%
Accumulated Depreciation
567.8M
+15.59%
491.2M
+14.71%
428.2M
+11.89%
382.7M
+11.77%
Property and Plant and Equipment and Net
1.7B
+41.50%
1.2B
+16.93%
1.0B
+21.35%
861.5M
+10.32%
Total Long-Term Assets
196.9M
-11.35%
222.1M
+46.31%
151.8M
+32.81%
114.3M
+5.64%
Total Assets
7.9B
+7.01%
7.4B
+2.75%
7.2B
+18.57%
6.0B
+16.94%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
0
-100.00%
300.0M
-25.00%
400.0M
N/A
N/A
N/A
Total Current Liabilities
560.6M
-24.05%
738.1M
-8.24%
804.4M
+134.38%
343.2M
+12.38%
Total Long-Term Debt
0
N/A
0
-100.00%
300.0M
-62.50%
800.0M
0.00%
Total Long-Term Liabilities
223.2M
+22.70%
181.9M
+133.80%
77.8M
-25.62%
104.6M
-0.19%
Total Liabilities
783.8M
-14.80%
920.0M
-22.18%
1.2B
-5.26%
1.2B
+3.11%
Retained Earnings
8.6B
+18.48%
7.2B
+19.83%
6.0B
+19.53%
5.0B
+16.86%
Total Stockholders Equity
7.1B
+10.12%
6.4B
+7.67%
6.0B
+24.77%
4.8B
+21.16%
Total Shares Outstanding
43.6M
-2.65%
44.8M
-4.70%
47.0M
+2.19%
46.0M
+2.05%
Cash Flow
Cash from Operating Activities
1.6B
+17.64%
1.3B
+35.70%
978.0M
+21.87%
802.5M
+34.15%
Capital Expenditures
520.5M
+111.16%
246.5M
+6.99%
230.4M
+65.99%
138.8M
+14.90%
Cash from Investing Activities
-551.3M
-232.14%
417.2M
+157.98%
-719.6M
-11.32%
-811.5M
+66.67%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-1.1B
-8.35%
-1.3B
+10,444.54%
-11.9M
-115.78%
75.4M
+68.30%
Financials Ratio
Gross Margin
87.92%
-1.47%
89.24%
+0.34%
88.94%
-3.51%
92.17%
-0.61%
Operating Margin
46.89%
-2.01%
47.86%
-6.00%
50.91%
+0.62%
50.60%
+53.41%
Return on Assets
17.51%
+6.46%
16.45%
+10.34%
14.91%
+14.93%
12.97%
+33.37%
Return on Equity
19.71%
+2.51%
19.23%
+5.27%
18.27%
+9.96%
16.61%
+28.39%
Revenue Growth
10.61%
-55.09%
23.63%
+16.94%
20.20%
+35.78%
14.88%
+9.16%
Current Ratio
6.60
+25.84%
5.25
+18.89%
4.41
-55.18%
9.85
+29.45%
Cash Ratio
2.78
+20.80%
2.30
+53.15%
1.50
-46.39%
2.80
-4.41%
Debt-to-Equity Ratio
0.00
-100.00%
0.05
-60.17%
0.12
N/A
N/A
N/A
Debt-to-Assets Ratio
0.00
-100.00%
0.04
-58.34%
0.10
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow